New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 9, 2014
10:17 EDTVC, IBN, TGTX, PPO, ERF High option volume stocks: IBN TGTX PPO ERF VC
News For IBN;TGTX;PPO;ERF;VC From The Last 14 Days
Check below for free stories on IBN;TGTX;PPO;ERF;VC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
09:08 EDTTGTXOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Chipotle (CMG), up 10.7%... Crocs (CROX), up 5%... Lockheed Martin (LMT), up 1.4%. ALSO HIGHER: GreenHunter Resources (GRH), up 10.3% after announcing intent to form MLP... TG Therapeutics (TGTX), up 9.5% after reporting Q2 results, preclinical study results, price target on shares raised to $19 from $13 at Brean Capital... FuelCell (FCEL), up 5.4% after announcing German government support, EUR 4.9M in research awards... Apache (APA), up 5.2% after Bloomberg says activist investor JANA Partners disclosed $1B position in the stock. DOWN AFTER EARNINGS: Harley-Davidson (HOG), down 4.1%... Travelers (TRV), down 3.4%... McDonald's (MCD), down 2.3%... Coca-Cola (KO), down 2.5%. ALSO LOWER: Amazon.com (AMZN), down 1% following downgrade to Neutral rating at Citigroup.
07:50 EDTPPOPolypore court ruling a 'significant positive,' says William Blair
William Blair views yesterday's U.S. District Court decision granting a motion by Polypore's subsidiary for a preliminary injunction against LG Chem as a "significant positive." The firm says the stock's flat reaction to the news creates a near-term buying opportunity and it keeps an Outperform rating on shares of Polypore.
07:34 EDTTGTXTG Therapeutics price target raised to $19 from $13 at Brean Capital
Subscribe for More Information
July 21, 2014
18:40 EDTTGTXOn The Fly: After Hours Movers
UP AFTER EARNINGS: Netflix (NFLX), up marginally after reporting Q2 results... Sanmina (SANM), up 13.2% after reporting third quarter results and fourth quarter guidance above analyst estimates... Chipotle (CMG), up 10.1%... Helix (HLX), up 5.2%... Canadian National (CNI), up 1.13%... CYS Investments (CYS), up 1.7%. ALSO HIGHER: Apache (APA), up 5% after Bloomberg says JANA discloses $1B position... Johnson & Johnson (JNJ), up 1% after announcing a $5B share repurchase program... TG Therapeutics (TGTX), up 4.3% after reporting second quarter results and preliminary clinical results from TG-1101 Phase I study... DOWN AFTER EARNINGS: Rambus (RMBS), down 3.6% after reporting second quarter results... Ultra Clean (UCTT), down 4% after reporting quarterly results. ALSO LOWER: Tallgrass Energy (TEP), down 5% after filing to sell 7M common units representing limited partners.
18:13 EDTTGTXTG Therapeutics to host conference call
Subscribe for More Information
16:30 EDTTGTXTG Therapeutics up 4.3% after reporting Q2 results, preclinical study results
16:15 EDTTGTXTG Therapeutics reports preliminary clinical results from TG-1101 Phase I study
TG Therapeutics announced preliminary clinical results from its ongoing Phase I study of TG-1101, the company's novel glycoengineered anti-CD20 monoclonal antibody in combination with TGR-1202, the company's novel, once-daily PI3K delta inhibitor in patients with advanced CLL and non-Hodgkin's lymphoma. 100% of CLL/SLL patients had significant nodal reduction with either a normalization of or greater than or equal to 80% reduction in Blood Lymphocyte Count. 4 of 5 CLL/SLL patients achieved a partial response at first assessment, including a patient relapsed from a prior BTK-inhibitor, and the 5th patient with stable disease achieved a 44% nodal reduction pending next assessment. 2 of 5 heavily pretreated DLBCL patients achieved a PR, including one patient with GCB subtype refractory to prior therapy. Combination appears well tolerated with no dose-related increases in toxicity observed among patients treated to date
16:13 EDTTGTXTG Therapeutics reports Q2 EPS (36c), consensus (24c)
Subscribe for More Information
08:08 EDTPPOPolypore receives favorable ruling on preliminary injunction against LG Chem
Polypore announced that the United States District Court for the Western District of North Carolina has granted a motion by Celgard, a subsidiary of Polypore International, for a preliminary injunction against LG Chem, and LG Chem America. The judge's order granting the injunction is currently under seal; portions of the order may be released in the future at the court's discretion. Celgard had requested a preliminary injunction to prohibit the importation, sale or offer for sale in the United States and inducement of others to use, sell or offer for sale lithium-ion batteries, including batteries used in electric drive vehicles and consumer electronics, which contain LG's ceramic coated lithium-ion battery separator, until a full trial on the matter is concluded. The lawsuit and motion for injunction are based on Celgard's assertion that LG infringes Celgard's patent, which claims ceramic composite layer lithium-ion battery separators first developed by Celgard for high-energy rechargeable lithium-ion batteries.
07:13 EDTTGTXUniversity of Nebraska Medical Center to hold a conference
2014 Pan Pacific Lymphoma Conference to be held in Kohala Coast, Hawaii on July 21-25.
July 16, 2014
08:45 EDTVCVisteon agrees to transfer certain U.S. pension assets to Prudential
Subscribe for More Information
July 14, 2014
10:00 EDTVCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:38 EDTVCVisteon downgraded to Equal Weight from Overweight at Barclays
Subscribe for More Information
July 10, 2014
10:44 EDTVCTRW approached about buyout by ZF Friedrichshafen, Bloomberg says
Subscribe for More Information
10:42 EDTVCLear, Magna, Visteon higher after report of TRW takeover interest
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use